Status:
COMPLETED
Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia Intermedia
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Thalassemia
Eligibility:
All Genders
1-40 years
Brief Summary
The definition of Thalassemia Intermedia is not generally accepted and the specific clinical and laboratory characteristics varies between patients. Some patients are blood transfusion dependent and o...
Detailed Description
The characteristics that will be recorded from the medical files include: demographic data, included gender and ethnic origin, family history, age at diagnosis, number and frequency of blood transfusi...
Eligibility Criteria
Inclusion
- All patients treated at the Pediatric Hematology Unit
Exclusion
- Not enough medical records.
- Patients who refuse to give consent to perform genetic studies will be included in the study but only the retrospective clinical data will be recorded.
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT01443312
Start Date
October 1 2011
End Date
December 1 2014
Last Update
November 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Hematology Unit - Ha'Emek Medical Center
Afula, Israel, 18101